News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Giordano Michael F
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
05/25/2023 |
4
| Giordano Michael F (Director) has filed a Form 4 on RAPT Therapeutics, Inc.
Txns:
| Granted 12,940 options to buy
@ $20.93, valued at
$270.8k
|
|
08/16/2022 |
4
| Giordano Michael F (Director) has filed a Form 4 on Epizyme, Inc.
Txns:
| Disposed/sold 8,060 shares
@ $0 Disposed/sold 8,994 shares
@ $0 |
|
05/26/2022 |
4
| Giordano Michael F (Director) has filed a Form 4 on RAPT Therapeutics, Inc.
Txns:
| Granted 8,500 options to buy
@ $13.64, valued at
$115.9k
|
|
05/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/04/2022 |
4
| Giordano Michael F (Director) has filed a Form 4 on RAPT Therapeutics, Inc.
Txns:
| Granted 3,213 options to buy
@ $21.99, valued at
$70.7k
|
|
06/24/2021 |
4
| Giordano Michael F (Director) has filed a Form 4 on RAPT Therapeutics, Inc.
Txns:
| Granted 7,500 options to buy
@ $19.3, valued at
$144.8k
|
|
06/15/2021 |
4
| Giordano Michael F (Director) has filed a Form 4 on Epizyme, Inc.
Txns:
| Granted 8,060 shares
@ $0 Granted 40,559 options to buy
@ $8.53, valued at
$346k
|
|
06/26/2020 |
4
| Giordano Michael F (Director) has filed a Form 4 on RAPT Therapeutics, Inc.
Txns:
| Sold 19,013 shares
@ $33.37, valued at
$634.5k
Exercised 10,069 options to buy
@ $6.18, valued at
$62.2k
Exercised 8,944 options to buy
@ $12, valued at
$107.3k
|
|
06/19/2020 |
4
| Giordano Michael F (Director) has filed a Form 4 on RAPT Therapeutics, Inc.
Txns:
| Granted 7,500 options to buy
@ $28.27, valued at
$212k
|
|
06/02/2020 |
4
| Giordano Michael F (Director) has filed a Form 4 on Epizyme, Inc.
Txns:
| Granted 14,013 options to buy
@ $17.55, valued at
$245.9k
|
|
11/01/2019 |
4
| Giordano Michael F (Director) has filed a Form 4 on RAPT Therapeutics, Inc.
Txns:
| Granted 15,334 options to buy
@ $12, valued at
$184k
|
|
10/30/2019 |
3
| Giordano Michael F (Director) has filed a Form 3 on RAPT Therapeutics, Inc. |
06/07/2019 |
4
| Giordano Michael F (Director) has filed a Form 4 on Epizyme, Inc.
Txns:
| Granted 17,633 options to buy
@ $13.74, valued at
$242.3k
|
|
03/12/2018 |
4
| Giordano Michael F (Director) has filed a Form 4 on Epizyme, Inc.
Txns:
| Granted 25,000 options to buy
@ $17.6, valued at
$440k
|
|
03/12/2018 |
3
| Giordano Michael F (Director) has filed a Form 3 on Epizyme, Inc. |
|
|